Brief: SHOP APOTHEKE EUROPE H1 EBIT loss at 7.1 mln euros

Redcare Pharmacy NV

26/07/2017 06:00

July 26 (Reuters) - SHOP APOTHEKE EUROPE NV  SAEG.BE  
    * CONSOLIDATED REVENUES FOR FIRST HALF OF 2017 ROSE BY 54% 
TO EUR 127M 
    * H1 CONSOLIDATED GROSS PROFIT GREW BY +61% TO EUR 27M WITH 
GROSS MARGIN IMPROVING TO 21.5%. 
    * H1 EARNINGS BEFORE INTEREST AND TAXES (EBIT) WERE EUR 
-7.1M (PAST YEAR: EUR -4.9M). 
    * CONFIRMED ITS FORECAST FOR 2017 FISCAL YEAR, I.E. A 
45%-55% INCREASE IN CONSOLIDATED REVENUES 
    * EXPECTS A YEAR-ON-YEAR IMPROVEMENT OF COMPANY-LEVEL 
EBITDA MARGIN TO AROUND -2% TO -3% (COMPARED TO -3.3% A YEAR 
EARLIER) 
 
Source text for Eikon:  ID:nEQ1rYqM0a  
Further company coverage:  SAEG.BE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))